The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates

被引:0
|
作者
Leigh Marcus
Robert Murphy
Elizabeth Fox
Cynthia McCully
Raphael Cruz
Katherine E. Warren
Thorsten Meyer
Edward McNiff
Frank M. Balis
Brigitte C. Widemann
机构
[1] National Cancer Institute,
[2] Pediatric Oncology Branch,undefined
[3] Children’s Hospital of Philadelphia,undefined
[4] Agennix,undefined
[5] Agennix,undefined
来源
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词
Pharmocology; Non-human primate; Satraplatin; Pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:247 / 252
页数:5
相关论文
共 50 条
  • [21] Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates
    Kilburn, Lindsay B.
    Bonate, Peter L.
    Blaney, Susan M.
    McGuffey, Leticia
    Nuchtern, Jed G.
    Dauser, Robert
    Thompson, Patrick
    Gibson, Brian W.
    Berg, Stacey L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 335 - 340
  • [22] Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primates
    Lindsay B. Kilburn
    Peter L. Bonate
    Susan M. Blaney
    Leticia McGuffey
    Jed G. Nuchtern
    Robert Dauser
    Patrick Thompson
    Brian W. Gibson
    Stacey L. Berg
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 335 - 340
  • [23] Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates
    Katherine E. Warren
    Cindy McCully
    Henrik Dvinge
    Jette Tjørnelund
    Maxwell Sehested
    Henri S. Lichenstein
    Frank M. Balis
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 433 - 437
  • [24] Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates
    Warren, Katherine E.
    McCully, Cindy
    Dvinge, Henrik
    Tjornelund, Jette
    Sehested, Maxwell
    Lichenstein, Henri S.
    Balis, Frank M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 433 - 437
  • [25] Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model
    Cole, Diane E.
    Lester-McCully, Cynthia M.
    Widemann, Brigitte C.
    Warren, Katherine E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 923 - 928
  • [26] Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model
    Diane E. Cole
    Cynthia M. Lester-McCully
    Brigitte C. Widemann
    Katherine E. Warren
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 923 - 928
  • [27] Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model
    James C. League-Pascual
    Cynthia M. Lester-McCully
    Shaefali Shandilya
    Lukas Ronner
    Louis Rodgers
    Rafael Cruz
    Cody J. Peer
    William D. Figg
    Katherine E. Warren
    Journal of Neuro-Oncology, 2017, 132 : 401 - 407
  • [28] Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model
    League-Pascual, James C.
    Lester-McCully, Cynthia M.
    Shandilya, Shaefali
    Ronner, Lukas
    Rodgers, Louis
    Cruz, Rafael
    Peer, Cody J.
    Figg, William D.
    Warren, Katherine E.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 132 (03) : 401 - 407
  • [29] Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates
    Muscal, Jodi A.
    Sun, Yongkai
    Nuchtern, Jed G.
    Dauser, Robert C.
    McGuffey, Leticia H.
    Gibson, Brian W.
    Berg, Stacey L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 943 - 947
  • [30] Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates
    Jodi A. Muscal
    Yongkai Sun
    Jed G. Nuchtern
    Robert C. Dauser
    Leticia H. McGuffey
    Brian W. Gibson
    Stacey L. Berg
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 943 - 947